Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $30.2 million.

  • Lifecore Biomedical's Total Current Liabilities fell 22.37% to $30.2 million in Q2 2025 from the same period last year, while for May 2025 it was $30.2 million, marking a year-over-year decrease of 22.37%. This contributed to the annual value of $30.2 million for FY2025, which is 22.37% down from last year.
  • Lifecore Biomedical's Total Current Liabilities amounted to $30.2 million in FY2025, which was down 22.37% from $38.9 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Total Current Liabilities ranged from a high of $176.6 million in FY2022 and a low of $30.2 million during FY2025.
  • In the last 3 years, Lifecore Biomedical's Total Current Liabilities had a median value of $38.9 million in 2024 and averaged $36.1 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 73.37% in 2022, then plummeted by 77.75% in 2023.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Total Current Liabilities stood at $101.9 million in 2021, then soared by 73.37% to $176.6 million in 2022, then tumbled by 77.75% to $39.3 million in 2023, then declined by 1.06% to $38.9 million in 2024, then fell by 22.37% to $30.2 million in 2025.